Interruption of Pregnancy by Prostaglandin 15-Methyl F2
- 1 July 1975
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 26 (7) , 695-699
- https://doi.org/10.1016/s0015-0282(16)41237-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Prostaglandin E2 vaginal suppository as a midtrimester abortifacientAmerican Journal of Obstetrics and Gynecology, 1974
- Mid-trimester abortion with 15 (S) methyl prostaglandin F2αProstaglandins, 1974
- Midtrimester Abortion Using Prostaglandin F2α, Oxytocin, and Laminaria**Supported by The Upjohn Company, Kalamazoo, Michigan.††Presented at the Twenty-Ninth Annual Meeting of The American Fertility Society, April 5–7, 1973, San Francisco, California.Fertility and Sterility, 1973
- Intra-amniotic prostaglandin administration — A challenge to the currently used methods for induction of midtrimester abortionContraception, 1973
- TERMINATION OF SECOND TRIMESTER PREGNANCY WITH 15 METHYL ANALOGUES OF PROSTAGLANDINS E2, AND F2xBJOG: An International Journal of Obstetrics and Gynaecology, 1972
- Activity of 15[S]15-Methyl prostaglandin E2 and F2α as stimulants of uterine contractilityProstaglandins, 1972
- NOVEL PROSTAGLANDIN SYNTHESESAnnals of the New York Academy of Sciences, 1971